90170881
Sep 10, 2020
Topical preparations; Topical preparations that target symptoms associated with Peripheral Artery Disease (PAD) and Diabetic Neuropathies containing cannabinoids solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis; Topical preparations for treatment of pain associated with Peripheral Artery Disease (PAD) and Diabetic Neuropathies containing cannabinoids solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis
Pharmaceuticals